Frequently Asked Question
The global Synthetic Bone Graft Substitutes market was valued at USD 1.1 Billion in 2022.
The Synthetic Bone Graft Substitutes market is expected to grow at a CAGR of 6.80% between 2023 and 2030, reaching USD 1.74 Billion in 2030.
The synthetic segment accounts for over forty percent of the market share.
The spinal fusion market segment accounts for over 30.9% of the market share.
The fastest growing segment is the foot & ankle segment.
North America is the greatest market, accounting for over 42.5% of the total market share.
The top players include AlloSource, Baxter, DePuy Synthes, Medtronic, NuVasive, Inc., Orthofix Medical, Inc., Smith + Nephew, Stryker., OST Laboratories, Zimmer Biomet, Geistlich Pharma AG, TBF, and Biobank.
The growing prevalence of bone disease and awareness regarding bone substitutes are the major market drivers.
The major market restraints include reimbursement challenges and the high surgery cost.
The growing geriatric population and rising demand for minimally invasive surgeries are the major opportunities in the Synthetic Bone Graft Substitutes industry.